Related Experiment Video
Updated: Jun 18, 2026

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension
Published on: May 17, 2024
Ischemic stroke and hyperhomocysteinemia: truth or myth?
A Terwecoren1, E Steen, D Benoit
1Department of Neurology, Ghent University, Ghent, Belgium. Annelies.Terwecoren@Ugent.be
Insights
High homocysteine levels (hyperhomocysteinemia) are linked to stroke risk, though a direct cause isn't confirmed. Testing and vitamin B treatment are recommended for certain stroke patients, but long-term benefits need more study.
Area of Science:
- Cardiovascular Science
- Neurology
- Metabolic Disorders
Background:
- Hyperhomocysteinemia, an elevation of homocysteine in the blood, is recognized as a potential risk factor for atherothrombotic diseases.
- The condition arises from disruptions in the methionine-homocysteine metabolism, involving enzyme deficiencies, vitamin shortfalls, and other contributing elements.
Observation:
- Observational studies, genetic analyses, and meta-analyses suggest a causal link between homocysteine levels and cerebrovascular diseases.
- Elevated homocysteine warrants investigation in patients with unexplained vascular disease or thrombosis, young ischemic stroke patients, and those with a family history of early atherosclerosis.
Findings:
- While a definitive causal relationship between hyperhomocysteinemia and atherothrombotic diseases is still under investigation, evidence implicates homocysteine in cerebrovascular conditions.
- Current guidelines recommend testing homocysteine levels in specific stroke patient groups.
Implications:
- The American Heart and Stroke Association suggests daily supplementation with folic acid, vitamin B12, and vitamin B6 for stroke patients with hyperhomocysteinemia due to the therapy's low cost and safety.
- However, conclusive evidence demonstrating significant benefits in secondary stroke prevention is pending further large-scale trial results.
Abstract:
Hyperhomocysteinemia is generally acknowledged as a treatable risk factor for atherotrombotic diseases, but a causal relationship between both is not yet definitively established. Hyperhomocysteinemia originates from a deviation in the methionine-homocysteine metabolism including disturbances of enzymes, vitamin deficiencies and different other factors. Observational studies, genetic polymorphism studies and several meta-analyses implicate already a causal relation between homocysteine and cerebrovascular diseases. It is useful to determine homocysteine levels for stroke who present no clue for vascular disease and thrombosis, who have an ischemic stroke at a young age and who have a family history of premature atherosclerosis. Because of the low cost and safety of the therapy, the American Heart and Stroke Association advises to treat patients with a stroke and hyperhomocysteinemia daily with 0,4 mg folic acid, 2,4 microg vitamin B12 and 1,7 mg vitamin B6. A significant benefit in secondary prevention is not yet proven. The results of larger follow-up trials have to be published.
Related Concept Videos
Ischemic Stroke l: Introduction
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke ll: Pathophysiology
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
